Belantamab Mafodotin,Pomalidomide,Dexamethasone,bortezomib,pomalidomide
GSK,janssen
['mmsm', 'dreamm-3', 'belantamab', 'pomalidomide', 'dreamm', '7 and 8']
a tough dream to remember - dreamm-3 belantamab did not improve pfs when compared to pomalidomide due to hr 1.03. this led to removal from the market but other dreamms (7 and 8) are pending #asco23 #mmsm #mediq23asco 
Hematologist, Myeloma Expert, Communication Enthusiast. Professor at TGen/City of Hope and Chief Medical Officer of the International Myeloma Foundation